|
CN107969126A
|
|
The cell-penetrating inhibitor peptides of JNK signal transduction pathways are used for the new application for treating mild cognitive impairment
|
|
WO2016055160A2
|
|
New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
CN106714821A
|
|
New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
EP3160989A2
|
|
New use for jnk inhibitor molecules for treatment of various diseases
|
|
AU2014274520A1
|
|
Novel transporter constructs and transporter cargo conjugate molecules
|
|
WO2015197097A1
|
|
New use for jnk inhibitor molecules for treatment of various diseases
|
|
WO2015197098A1
|
|
New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
KR20160023669A
|
|
New use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases
|
|
AU2013263786A1
|
|
Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases
|
|
WO2014206426A1
|
|
New use for jnk inhibitor molecules for treatment of various diseases
|
|
WO2014206427A1
|
|
New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
EP2785363A1
|
|
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of dry eye syndrome
|
|
MX2014006399A
|
|
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of dry eye syndrome.
|
|
AU2012203529A1
|
|
Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
|
|
EP2627346A1
|
|
Cell-permeable peptide inhibitors of the jnk signal transduction pathway for use in the treatment of uveitis
|
